Neonatal adrenal hemorrhage
ICD-10 P54.4 is a billable code used to indicate a diagnosis of neonatal adrenal hemorrhage.
Neonatal adrenal hemorrhage is a condition characterized by bleeding into the adrenal glands of newborns, which can occur due to various factors including birth trauma, hypoxia, or coagulopathy. This condition is often associated with significant morbidity, particularly in premature infants or those with low birth weight. Clinically, it may present with signs of adrenal insufficiency, such as hypotension, electrolyte imbalances, and shock. Diagnosis is typically confirmed through imaging studies, such as ultrasound or CT scans, which reveal the presence of hematoma in the adrenal glands. Management may involve supportive care, monitoring of vital signs, and in some cases, surgical intervention if there is significant hemorrhage or adrenal dysfunction. The prognosis is generally favorable with appropriate management, although long-term follow-up may be necessary to monitor for potential complications, including adrenal insufficiency.
Detailed documentation of clinical findings, imaging results, and treatment plans.
Management of premature infants with adrenal hemorrhage in the NICU.
Consideration of gestational age and birth weight in coding.
Comprehensive documentation of pediatric assessments and follow-up care.
Pediatric follow-up for infants with a history of adrenal hemorrhage.
Monitoring for long-term effects of adrenal insufficiency.
Used to confirm diagnosis of adrenal hemorrhage in neonates.
Document indications for ultrasound and findings.
Neonatologists should ensure imaging is performed and interpreted correctly.
Common causes include birth trauma, hypoxia during delivery, and underlying coagulopathies. It is essential to assess the infant's clinical history and any complications during delivery.